Alena Heimsoeth

538 total citations
5 papers, 148 citations indexed

About

Alena Heimsoeth is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alena Heimsoeth has authored 5 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alena Heimsoeth's work include Testicular diseases and treatments (2 papers), Sperm and Testicular Function (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Alena Heimsoeth is often cited by papers focused on Testicular diseases and treatments (2 papers), Sperm and Testicular Function (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Alena Heimsoeth collaborates with scholars based in Germany and United States. Alena Heimsoeth's co-authors include Hannah L. Tumbrink, Martin L. Sos, Hubert Schorle, Sina Jostes, Daniel Nettersheim, Andrea Hofmann, Martin Fellermeyer, Simon Schneider, Daniel Rauh and Jonas Lategahn and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Alena Heimsoeth

5 papers receiving 147 citations

Peers

Alena Heimsoeth

MB

PRM

SURGE

ONCOL

CR

Michelle G. Richards Australia

Elodie Noël United Kingdom

Takuma Onoe Japan

Stefania Pipitone Italy

Ming-Mo Hou Taiwan

Jinyeong Lim South Korea

Christin Lund‐Andersen Norway

Melanie Ongchin United States

Jimin Min United States

Victoria Damerell South Africa

Michelle G. Richards Australia

Alena Heimsoeth

106 ×1.1

MB

86 ×1.4

PRM

29 ×0.6

SURGE

61 ×1.7

ONCOL

33 ×1.2

CR

Citations per year, relative to Alena Heimsoeth Alena Heimsoeth (= 1×) peers Michelle G. Richards

Countries citing papers authored by Alena Heimsoeth

Since Specialization

Citations

This map shows the geographic impact of Alena Heimsoeth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alena Heimsoeth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alena Heimsoeth more than expected).

Fields of papers citing papers by Alena Heimsoeth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alena Heimsoeth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alena Heimsoeth. The network helps show where Alena Heimsoeth may publish in the future.

Co-authorship network of co-authors of Alena Heimsoeth

This figure shows the co-authorship network connecting the top 25 collaborators of Alena Heimsoeth. A scholar is included among the top collaborators of Alena Heimsoeth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alena Heimsoeth. Alena Heimsoeth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Lorenz, Carina, Maria Cartolano, Dennis Plenker, et al.. (2023). Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer. Cancer Research. 83(15). 2471–2479. 7 indexed citations

2.

Tumbrink, Hannah L., Alena Heimsoeth, & Martin L. Sos. (2020). The next tier of EGFR resistance mutations in lung cancer. Oncogene. 40(1). 1–11. 80 indexed citations

3.

Nettersheim, Daniel, et al.. (2019). TCam-2 Cells Deficient for SOX2 and FOXA2 Are Blocked in Differentiation and Maintain a Seminoma-Like Cell Fate In Vivo. Cancers. 11(5). 728–728. 16 indexed citations

4.

Sos, Martin L., Hannah L. Tumbrink, Carsten Schultz‐Fademrecht, et al.. (2019). Targeting EGFR Ex20 mutant lung cancer with the wild type sparing kinase inhibitor PRB001.. Journal of Clinical Oncology. 37(15_suppl). e14718–e14718. 1 indexed citations

5.

Nettersheim, Daniel, Alena Heimsoeth, Sina Jostes, et al.. (2016). SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate. Oncotarget. 7(30). 47095–47110. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact